Linifanib (GMP)

Overview

Linifanib (ABT-869) (GMP) is Linifanib ( HY-50751 ) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC 50 s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ , and FLT3 , respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells.

Application

Products | Products > GMP Small Molecules | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > PDGFR

Product Information

• Catalog No.: HY-50751G
• CAS No.: 796967-16-3
• Molecular Formula: C21H18FN5O
• Molecular Weight: 375.40
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source